Crizotinib enhances anti-CD30-LDM induced antitumor efficacy in NPM-ALK positive anaplastic large cell lymphoma Cancer Lett 448, 84-93 (2019) Read more
Specific Decrease in B-Cell-Derived Extracellular Vesicles Enhances Post-Chemotherapeutic CD8+ T Cell Responses Immunity 50, 738-750.e737 (2019). Read more
FOXO3-Engineered Human ESC-Derived Vascular Cells Promote Vascular Protection and Regeneration Cell Stem Cell 24, 447-461.e448 (2019). Read more
B7‐H5/CD28H is a co‐stimulatory pathway and correlates with improved prognosis in pancreatic ductal adenocarcinoma Cancer Sci 110, 530-539 (2019). Read more
A novel CD7 chimeric antigen receptor-modified NK-92MI cell line targeting T-cell acute lymphoblastic leukemia Am J Cancer Res 9, 64-78 (2019). Read more
Wedelolactone suppresses cell proliferation and migration through AKT and AMPK signaling in melanoma J Dermatolog Treat, 1-7 (2018). Read more
High PARP-1 expression predicts poor survival in acute myeloid leukemia and PARP-1 inhibitor and SAHA-bendamustine hybrid inhibitor combination treatment synergistically enhances anti-tumor effects EBioMedicine 38, 47-56 (2018). Read more
Compound kushen injection suppresses human acute myeloid leukaemia by regulating the Prdxs/ROS/Trx1 signalling pathway J Exp Clin Cancer Res 37, 277 (2018). Read more
Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis J Exp Clin Cancer Res 37, 276 (2018). Read more
CD47 Blockade Inhibits Tumor Progression through Promoting Phagocytosis of Tumor Cells by M2 Polarized Macrophages in Endometrial Cancer J Immunol Res 2018, 6156757 (2018). Read more
